159 related articles for article (PubMed ID: 14559371)
1. Breast cancer and hormone-replacement therapy in the Million Women Study.
Crosignani PG
Maturitas; 2003 Oct; 46(2):91-2. PubMed ID: 14559371
[No Abstract] [Full Text] [Related]
2. Some comments on the Million Women Study.
Neves-E-Castro M
Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
[No Abstract] [Full Text] [Related]
3. Breast cancer and hormone-replacement therapy: the Million Women Study.
Helmond FA
Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575988
[No Abstract] [Full Text] [Related]
4. Breast cancer and hormone-replacement therapy: the Million Women Study.
Bundred NJ; Morris J
Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
[No Abstract] [Full Text] [Related]
5. The sound of an International anti-HRT herald.
Genazzani AR; Gambacciani M
Maturitas; 2003 Oct; 46(2):105-6. PubMed ID: 14559378
[No Abstract] [Full Text] [Related]
6. Oestrogens and progestins and breast cancer risk in post-menopausal women.
La Vecchia C
Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479
[No Abstract] [Full Text] [Related]
7. Breast cancer and hormone-replacement therapy: the Million Women Study.
Garton M
Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
[No Abstract] [Full Text] [Related]
8. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
9. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
Schairer C; Brinton LA
J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
[No Abstract] [Full Text] [Related]
10. Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
Shapiro S; deVilliers TJ; Pines A; Sturdee DW; Archer DF; Baber RJ; Panay N; Farmer RD; Stevenson JC; Mueck AO; Burger HG; Gompel A
J Natl Cancer Inst; 2014 Feb; 106(2):djt372. PubMed ID: 24363446
[No Abstract] [Full Text] [Related]
11. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Archer DF; Bush T; Nachtigall LE
J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
[No Abstract] [Full Text] [Related]
12. Study outlines further risks associated with hormone replacement therapy.
Rollins G
Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):1-2, 5. PubMed ID: 13677336
[No Abstract] [Full Text] [Related]
13. Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study.
Herd JA; Gotto AM
Pharmacol Res; 1995 Dec; 32(6):331-3. PubMed ID: 8736483
[No Abstract] [Full Text] [Related]
14. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Grant EC
J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
[No Abstract] [Full Text] [Related]
15. Hormone replacement therapy and breast cancer.
Stanford JL; Weiss NS
Arch Fam Med; 1996 Jun; 5(6):349-50. PubMed ID: 8640325
[No Abstract] [Full Text] [Related]
16. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Kuller LH
J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
[No Abstract] [Full Text] [Related]
17. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
18. Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589.
Sismondi P; Biglia N
Pharmacol Res; 1995 Dec; 32(6):329-30. PubMed ID: 8736482
[No Abstract] [Full Text] [Related]
19. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
20. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
